JBATX
Price
$27.32
Change
+$1.30 (+5.00%)
Updated
Apr 9 closing price
Net Assets
5.12B
RLBBX
Price
$33.19
Change
+$1.61 (+5.10%)
Updated
Apr 9 closing price
Net Assets
228.54B
Ad is loading...

JBATX vs RLBBX

Header iconJBATX vs RLBBX Comparison
Open Charts JBATX vs RLBBXBanner chart's image
JHancock Balanced R2
Price$27.32
Change+$1.30 (+5.00%)
VolumeN/A
Net Assets5.12B
American Funds American Balanced R2
Price$33.19
Change+$1.61 (+5.10%)
VolumeN/A
Net Assets228.54B
JBATX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JBATX vs. RLBBX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBATX is a Buy and RLBBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 229B vs. JBATX (5.12B). JBATX pays higher dividends than RLBBX: JBATX (1.53) vs RLBBX (1.27). JBATX was incepted earlier than RLBBX: JBATX (13 years) vs RLBBX (23 years). RLBBX (1.33) is less costly to investors than JBATX (1.13). RLBBX is a more actively managed with annual turnover of: 171.00 vs. JBATX (67.00). JBATX has a lower initial minimum investment than RLBBX: JBATX (0) vs RLBBX (250). RLBBX annual gain was more profitable for investors over the last year : -4.31 vs. JBATX (-5.45). JBATX return over 5 years is better than : 38.04 vs. RLBBX (26.14).
JBATXRLBBXJBATX / RLBBX
Total Expense Ratio1.121.3384%
Annual Report Gross Expense Ratio1.131.3385%
Fund Existence13 years23 years-
Gain YTD-8.610-7.136121%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.12B229B2%
Annual Yield % from dividends1.531.27121%
Returns for 1 year-5.45-4.31126%
Returns for 3 years6.643.16211%
Returns for 5 years38.0426.14146%
Returns for 10 years50.2234.16147%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VHIAX30.18N/A
N/A
JPMorgan Growth Advantage A
ETCGX34.85N/A
N/A
Eventide Gilead C
SMFYX31.62N/A
N/A
American Beacon Stephens Mid-Cap Gr Y
IGFSX14.43N/A
N/A
VY® Morgan Stanley Global Franchise S2
RECRX10.62N/A
N/A
RBC Emerging Markets Ex-China Equity R6